GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMUX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Immunic Inc. stock still a buy after falling -5.47% on Wednesday?
(Updated on Apr 17, 2024)

Sell candidate since Apr 15, 2024 Loss -7.63% PDF

The Immunic Inc. stock price fell by -5.47% on the last day (Wednesday, 17th Apr 2024) from $1.28 to $1.21. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.61% from a day low at $1.21 to a day high of $1.29. The price has risen in 6 of the last 10 days but is still down by -0.82% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -84 thousand shares and in total, 181 thousand shares were bought and sold for approximately $218.94 thousand.

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $1.25. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMUX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immunic Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.33 and $1.35. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -15.97%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Immunic Inc. stock

Immunic Inc. finds support from accumulated volume at $1.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0800 between high and low, or 6.61%. For the last week the stock has had daily average volatility of 7.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMUX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Immunic Inc. to open at $1.24, and during the day (based on 14 day Average True Range), to move between $1.12 and $1.30, which gives a possible trading interval of +/-$0.0911 (+/-7.53%) up or down from last closing price. If Immunic Inc. takes out the full calculated possible swing range there will be an estimated 15.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.22 (0.83%) than the support at $1.19 (1.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immunic Inc. stock A Buy?

The Immunic Inc. stock holds several negative signals and despite the positive trend, we believe Immunic Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.219 Sell Candidate Unchanged

Predicted Opening Price for Immunic Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$1.24 ( 2.20%) $1.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMUX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.32 8.82 %
R2 1.29 6.29 %
R1 1.27 4.73 %
Current price: 1.21
Support S1 1.21 -0.322 %
S2 1.19 -1.88 %
S3 1.16 -4.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.31 8.26 %
R2 1.28 5.79 %
R1 1.22 0.83 %
Current price 1.21
Support S1 1.19 -1.65%
S2 1.16 -4.13%
S3 1.15 -5.37%

FAQ

What is the symbol for Immunic Inc. Stock and on which exchange is it traded?
The symbol for Immunic Inc. is IMUX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immunic Inc. Stock?
The Immunic Inc. stock holds several negative signals and despite the positive trend, we believe Immunic Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Immunic Inc. Stock?
Immunic Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immunic Inc. Stock.

What's the current price of Immunic Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Immunic Inc. (IMUX) share was $1.21.

What is the 52-week high and low for Immunic Inc. Stock?
The 52-week high for Immunic Inc. Stock is $3.11 and the 52-week low is $0.95.

What is the market capitalization of Immunic Inc. Stock?
As of the 2024-04-17, the market capitalization of Immunic Inc. is 108.814M.

When is the next earnings date for Immunic Inc.?
The upcoming earnings date for Immunic Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Immunic Inc.

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company i... IMUX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT